Central India Institute Of Haematology And Oncology Private Limited - Company Profile

It is a healthcare private limited company based in Nagpur, Maharashtra, India, established in 2011.
2011 Nagpur, Maharashtra, India Active
Last Updated:
Access Report
About Central India Institute Of Haematology And Oncology Private Limited

Central India Institute Of Haematology And Oncology Private Limited, a active private limited company, was established on 12 May 2011 in Nagpur, Maharashtra, India. Engaging in preventive health services within the hospital and medical care sector, it holds CIN: U85100MH2011PTC217386. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Employing 21 professional, Its leadership includes Surekha Avinash Pophali (Director), Avinash Keshaorao Pophali (Director). Past directors included Prateek Pophali, Prachi Avinash Pophali, Priyanka Avinash Pophali. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 169, Abhyankar Nagar, Nagpur, Maharashtra, 440010.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85100MH2011PTC217386

  • Registration Number

    217386

  • Incorporation Date

    12 May 2011

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 14 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** -11.48%
  • Profit Growth **** -38.80%
  • Ebitda **** -36.06%
  • Net Worth 5.27%
  • Total Assets -17.26%
Company report

Central India Institute Of Haematology And Oncology Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Central India Institute Of Haematology And Oncology Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Central India Institute Of Haematology And Oncology Private Limited?
Current Directors
Name Designation Appointment Date Status
Surekha Avinash Pophali Director 12 May 2011 Current
Avinash Keshaorao Pophali Director 12 May 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Director 21 Dec 2022 Past
Pramod Abcsdd Director 21 Dec 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Central India Institute Of Haematology And Oncology.

Central India Institute Of Haematology And Oncology Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 11.48% decrease. The company also saw a substantial fall in profitability, with a 38.8% decrease in profit. The company's net worth moved up by a moderate rise of 5.27%.

Central India Institute Of Haematology And Oncology revenue growth over time
Central India Institute Of Haematology And Oncology profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -11.48%
*******
*******
*******
*******
Revenue from Operations
*******
 -11.60%
*******
*******
*******
*******
Total Assets
*******
 -17.26%
*******
*******
*******
*******
Profit or Loss
*******
 -38.80%
*******
*******
*******
*******
Net Worth
*******
 5.27%
*******
*******
*******
*******
EBITDA
*******
 -36.06%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Central India Institute Of Haematology And Oncology?

In 2021, Central India Institute Of Haematology And Oncology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Central India Institute Of Haematology And Oncology?

Central India Institute Of Haematology And Oncology has a workforce of 21 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Central India Institute Of Haematology And Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Central India Institute Of Haematology And Oncology's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Central India Institute Of Haematology And Oncology
Recent Activity within the Organization
  • Annual General Meeting

    Central India Institute Of Haematology And Oncology Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Central India Institute Of Haematology And Oncology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.

  • Director Appointment

    Surekha Avinash Pophali was appointed as a Director was appointed as a Director on 12 May 2011 & has been associated with this company since 14 years 9 months . was recorded as a recent event.

  • Director Appointment

    The activity Avinash Keshaorao Pophali was appointed as a Director was appointed as a Director on 12 May 2011 & has been associated with this company since 14 years 9 months . was completed.

  • Company Incorporation

    Progress on Central India Institute Of Haematology And Oncology Private Limited was registered on 12 May 2011 with Roc Mumbai & aged 14 years 9 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Central India Institute Of Haematology And Oncology Private Limited?

The CIN of Central India Institute Of Haematology And Oncology Private Limited is U85100MH2011PTC217386.

Where is Central India Institute Of Haematology And Oncology Private Limited headquartered?

Central India Institute Of Haematology And Oncology Private Limited is headquartered at 169, Abhyankar Nagar, Nagpur, Maharashtra, 440010.

When was Central India Institute Of Haematology And Oncology Private Limited incorporated?

Central India Institute Of Haematology And Oncology Private Limited was incorporated on 12 May 2011.

Who are the current directors of Central India Institute Of Haematology And Oncology Private Limited?

The current directors of Central India Institute Of Haematology And Oncology Private Limited are

What is the primary industry of Central India Institute Of Haematology And Oncology Private Limited?

The primary industry of Central India Institute Of Haematology And Oncology Private Limited is Hospital And Medical Care.

Is Central India Institute Of Haematology And Oncology Private Limited a listed company?

Central India Institute Of Haematology And Oncology Private Limited is unlisted.

What is the capital structure of Central India Institute Of Haematology And Oncology Private Limited?

The authorized capital of Central India Institute Of Haematology And Oncology Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Central India Institute Of Haematology And Oncology Private Limited?

The compliance status of Central India Institute Of Haematology And Oncology Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available